Southern California Evidence-Based Practice Center/RAND & United States. Agency for Healthcare Research and Quality. (2004). Effects of omega-3 fatty acids on lipids and glycemic control in type II diabetes and the metabolic syndrome and on inflammatory bowel disease, rheumatoid arthritis, renal disease, systemic lupus erythematosus, and osteoporosis. [Agency for Healthcare Research and Quality, U.S. Dept. of Health and Human Services].
Chicago Style (17th ed.) CitationSouthern California Evidence-Based Practice Center/RAND and United States. Agency for Healthcare Research and Quality. Effects of Omega-3 Fatty Acids on Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal Disease, Systemic Lupus Erythematosus, and Osteoporosis. [Rockville, Md.]: [Agency for Healthcare Research and Quality, U.S. Dept. of Health and Human Services], 2004.
MLA (9th ed.) CitationSouthern California Evidence-Based Practice Center/RAND and United States. Agency for Healthcare Research and Quality. Effects of Omega-3 Fatty Acids on Lipids and Glycemic Control in Type II Diabetes and the Metabolic Syndrome and on Inflammatory Bowel Disease, Rheumatoid Arthritis, Renal Disease, Systemic Lupus Erythematosus, and Osteoporosis. [Agency for Healthcare Research and Quality, U.S. Dept. of Health and Human Services], 2004.